线性资本
@linearcapital
专注前沿科技早期投资
Articles
Journey to the West — Middle East Edition
From June to July 2023, I set off on a round-the-world trip. I started in Shanghai, headed to Beijing first, then on to the Middle East, Europe, the US, Singapore, and Hong Kong, before finally returning to Shanghai. The whole journey took roughly 70 days — the longest trip I've ever taken.
"Yimu Technology" announced the completion of a tens-of-millions RMB angel round, with Linear Capital as the sole investor.
Empowering the digital and intelligent transformation of ranches.
After 200+ Days of AIGC Fervor, Investors Reach Three Broad Consensuses
By Elune, edited by Jiumu, curated by Eason On July 19, Meta, Facebook's parent company, released the Llama 2 large language model, making it freely available for both research and commercial use — widely hailed as the most powerful open-source alternative to GPT-4. This marks a significant shift from the previous landscape, where numerous global large language models were built on Llama but constrained by its inability to be used commercially at no cost.
Linear Capital portfolio company **Baiyi Huixin** launches **DetecMicro**, a vascular interventional surgery planning software
On June 16, 2023, **Baiyi Huixin held its product launch event in Beijing under the theme "Seeing the Small to Know the Great, Moving to See the Future." At the event, the company unveiled its DetecMicro vascular interventional surgical planning software.**
Linear Capital Portfolio Company DigiSight Ophthalmic Surgery Robot Completes Asia's First Clinical Application of Ophthalmic Robotics
Recently, portfolio company of Linear Capital **Hangzhou Disight Medical Biotechnology Co., Ltd.** successfully completed its first retinal sub-thrombolysis surgery for treating macular hemorrhage using its **"Disight MicroEdge"** ophthalmic surgical robot at Zhejiang Provincial People's Hospital. The procedure was safe and smooth, the patient recovered well, and has since been discharged in stable condition. This marks the first clinical application of an ophthalmic robot in Asia, representing a major technological advance for the entire field of ophthalmic microsurgery.
Linear Academy | What We Discussed at the "ToB Tech Enterprise Operations Management Salon"
Not long ago, Linear Capital and its portfolio company Guandata co-hosted a "ToB Tech Company Operations Management Salon" — a "homework submission" event that followed up on a Huawei BLM workshop Linear Academy had organized for portfolio companies two years prior. It was warmly received by founders across Linear's portfolio. At the event, Monica, formerly a business operations specialist at Sensors Data, drew on her practical experience since first encountering Huawei's BLM to discuss "enterprise operations management systems."
Linear Capital Portfolio | Whales CEO Sheldon Ye's Chuan Talk: AGI Through Silicon Valley's Eyes, Chinese Companies' Long March
Last week, the Chuang Xue Yuan (Hundun Academy) 2023 "One" Thinking Innovation Carnival brought together "half of the AI circle." Jerry Ye, founder & CEO of Whale, was invited to speak, joining guests and attendees for a wide-ranging discussion on the application prospects of AGI.
Networking Sessions, Forums, and New Product Launches — Multiple Linear Capital Portfolio Companies Take the Stage at WAIC
Last week, the World Artificial Intelligence Conference (WAIC) took place in Shanghai. Can Zheng, Director at Linear Capital, served as a judge at the "ModelScope Create@AI Hackathon," hosted by AI model community ModelScope, guided by the CCF Open Source Development Committee, co-organized by Alibaba Cloud and NVIDIA, and supported by Alibaba Cloud Tianchi. For details on the three-day competition, [click here](https://mp.
Linear Capital is still recruiting for its overseas internship program!
We're focused on early-stage ventures powered by breakthrough technology. We're the investors who actually understand tech — and we're geeks who can think in business and strategy terms too. Enough said. Here's the JD.
Linear Capital's Pre-A lead portfolio company **DigiSight Medical** has closed a multi-million-yuan Pre-A+ round, with existing investor Linear Capital continuing to back the company.
Accelerating clinical trials and R&D for ophthalmic and microsurgical robotic products.